How Cronos Group Is Growing Its Core Medical Marijuana Business

📆 28/09/2018 04:21:00
📰 Forbes

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 53%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

Cronos Group has seen its stock price rise by over 70% over the last six months. While the rally has largely been driven by legalization in Canada and deal-making activity in the industry, Cronos’ bread-and-butter medical marijuana business is likely to remain a crucial driver for the company.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

Scrivi un Commento

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Altria in talks to buy cannabis company Cronos GroupMarlboro cigarette maker Altria is in early talks to acquire Canadian cannabis producer Cronos, as it seeks to diversify its business beyond traditional smokers, a person familiar with the matter told CNBC. 😳🙄 Uwu uwu...cokiegig88 it doesn't take much to get these guys going...
Fonte: CNBC - 🏆 12. / 72 Leggi di più »

Marlboro maker Altria is talking with pot producer Cronos about investmentMarlboro cigarette maker Altria Group Inc. is discussing an investment in marijuana producer Cronos Group Inc., as legacy companies continue to look for ways into the marijuana industry.
Fonte: MarketWatch - 🏆 3. / 97 Leggi di più »

Altria to invest $1.8 billion in cannabis company Cronos GroupAltria Group said Friday it agreed to buy a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion. That was the complete value of the company, as of yesterdays close. IMO Altria will own the company outright in a few years, with no more capital outlay. Bad idea legalizing dope. Drug dealers are now legal.
Fonte: CNBC - 🏆 12. / 72 Leggi di più »